Company · CIK 0001042561
CORIXA CORP
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0000903423-05-000521 · 55.7 KBSEC(opens sec.gov)
- 4Insider trades0001209191-05-037230 · 10.5 KBSEC(opens sec.gov)
- 4Insider trades0001209191-05-037227 · 12.3 KBSEC(opens sec.gov)
- 4Insider trades0001209191-05-037226 · 7.9 KBSEC(opens sec.gov)
- 4Insider trades0001209191-05-037225 · 16.7 KBSEC(opens sec.gov)
- 4Insider trades0001209191-05-037223 · 43.0 KBSEC(opens sec.gov)
- 4Insider trades0001209191-05-037221 · 52.0 KBSEC(opens sec.gov)
- 4Insider trades0001209191-05-037216 · 62.2 KBSEC(opens sec.gov)
- 4Insider trades0001209191-05-037208 · 59.1 KBSEC(opens sec.gov)
- 4Insider trades0001181340-05-000001 · 22.7 KBSEC(opens sec.gov)
Insiders
- BIGHAM MICHAELDirector
- CREDIT SUISSE AG/10% Owner
- FANNING DAVIDSr. Vice President, COO
- GILLIS STEVENDirector, CEO
- GRABSTEIN KENNETHExec. VP, Product Development
- GRIFFIN MICHELLE RENEESr. Vice President, CFO
- GSK plc10% Owner
- HUNT RONALDDirector
- JACOBS CINDYSr. VP, Clinical Development
- MCKEREGHAN KATHLEENSr. VP,General Counsel
Tickers
No tickers on record.
Addresses
business
1900 9TH AVENUE SUITE 1100
SEATTLE, WA, 98101
mailing
1900 9TH AVENUE SUITE 1100
SEATTLE, WA, 98101
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies